This course addresses basic pharmacology concepts including drug nomenclature and how the Food and Drug Administration (FDA) regulates and approves drugs in the USA. Implications of FDA guidelines for rehabilitation specialists will also be discussed. Pharmacokinetic concepts will then be addressed, including methods of drug administration, absorption, distribution, storage, and elimination. This content area concludes with a discussion of how specific factors can alter pharmacokinetic variables, and how altered drug disposition can have an impact on patients receiving physical rehabilitation.
This Course is the Prerequisite for the multi-course series "Pharmacology in Rehabilitation":
You may also be interested in the All-inclusive "Pharmacology in Rehabilitation" Course:
- Pharmacology in Rehabilitation (LMS-709)
cert_Insert Up To
cert_NV credit value
cert_OH approval code
cert_PA DA hours
cert_PA Ethics hours
cert_PA Gen hours
- Differentiate between a drug’s chemical, generic, and trade names, and describe how and why each name is created and used clinically.
- List the primary steps involved in FDA drug testing and approval.
- Relate how drug approval can impact on patients receiving physical rehabilitation.
- Describe primary pharmacokinetic principles, and judge how drug effects can be influenced by their administration, absorption, distribution, storage, and metabolism in the human body.
- List specific factors that can alter normal drug kinetics.
- Describe the primary ways that pharmacokinetic principles can impact on patients receiving physical rehabilitation.
Brought to you by
- Non Member$100.00(until 12/31/2030)
- Member$60.00(until 12/31/2030)